Olestra is a fat substitute approved by the FDA for use in snack foods. Because there have been anecdotal reports of gastrointestinal problems with it, a randomized, double-blind, placebo-controlled experiment was carried out to compare olestra potato chips to regular potato chips with respect to GI symptoms. Among 529 individuals in the control group (placebo group), 17.6 experienced and adverse GI event whereas among the 563 individuals in the olestra group 15.8% experienced such an event. If a group of 10000 people are given the olestra potato chips, what is the expected number of people to experience an adverse GI event?

1580

158

176

1760